Q4 2025 earnings call: ibezapolstat rCDI trial plan, FDA one-trial shift, cash update, and Phase II data—read now.
Acurx Pharmaceuticals (ACXP) stock jumped 218% after announcing a clinical trial for ibezapolstat, which showed 96% cure rate for C. difficile infection.
Russ can Fly on MSN
Mastering IFR flight perfecting CDI and altitude scan
Beginning My Instrument Rating Journey! | Piper Cherokee 235 Training with CFII Vanessa. Today marks the official start of my instrument rating journey, and wow… it’s already proving to be both ...
Each year, Tama Soil and Water Conservation District (SWCD) partners with Conservation Districts of Iowa (CDI) to help foster the higher education endeavors of Iowa high school seniors beginning ...
Acurx Pharmaceuticals Inc shares are trading sharply higher Wednesday afternoon despite a lack of company-specific news during the session.
In pulse-mode RF systems, the power supply can make or break performance. This article explains how a pulse-optimized ...
CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory University School of ...
Cleo Health announced the official debut of its Acute Care OS at HIMSS 2026 this week in Las Vegas, a first-of-its-kind platform unifying Charge Capture, Real-Time Clinical Docume ...
The Defence Intelligence College (DIC) has graduated 27 pioneer participants of VIP Protection Course 01/26, marking a significant step toward strengthening professional protective security operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results